UNIVERSITA DEGLI STUDI DELLA CAMPANIA LUIGI VANVITELLI

Their core work

University of Campania Luigi Vanvitelli is a southern Italian university with strong applied research across aerospace structures, health sciences, and energy systems. Their engineering departments contribute structural monitoring, robotics, and power electronics expertise to aviation and transport consortia, while their medical faculties engage in rare disease research, gene therapy trials, and neuroscience. They bridge materials science and clinical research in a way that makes them a versatile consortium partner across multiple EU programme pillars.

What they specialise in

How they've shifted over time

In their early H2020 period (2015–2018), the university focused on materials science fundamentals — catalysis, ferrites, semiconductors, shape memory alloys — alongside computational methods for energy applications. From 2019 onward, the focus shifted markedly toward health and society: sickle cell disease, mental health monitoring, chronic kidney disease, and energy transition topics like smart charging and solar industrial heat. The portfolio broadened from hard engineering into clinical research and human-centered technology.

Moving from fundamental materials research toward applied health technologies and human-centered systems, suggesting future collaborations in digital health, rare diseases, or sustainable energy integration are most likely to align with their trajectory.

How they like to work

Overwhelmingly a participant rather than a leader — they coordinated only 1 of 28 projects (BRIDAS, a Clean Sky 2 project). They work comfortably in large consortia, having collaborated with 320 unique partners across 33 countries, which indicates a hub-style network rather than a closed circle of repeat partners. This makes them an accessible, low-friction partner to bring into new consortia, though they are unlikely to take the lead on proposal writing or project management.

Extensive European network spanning 320 unique partners across 33 countries, with strong ties to the Clean Sky 2 aviation community and rare disease research networks (European Reference Networks). Their reach extends to Africa through the ARISE sickle cell project.

What sets them apart

Their unusual combination of aerospace engineering and clinical health research under one institutional roof makes them a rare find for cross-disciplinary consortia that need both technical and medical expertise. Based in Campania (southern Italy), they bring geographic diversity that strengthens proposals targeting EU cohesion and widening participation criteria. Their seven Clean Sky 2 projects demonstrate trusted, repeat engagement with one of Europe's most selective Joint Technology Initiatives.

Highlights from their portfolio

• UshTher
  Largest single EC contribution (EUR 700,567) for a gene therapy clinical trial targeting Usher syndrome — their most significant health research investment.
• BRIDAS
  Their only coordinated project, developing Brillouin distributed sensors for aeronautical structures — reveals their core competence in structural health monitoring.
• Solve-RD
  Part of the European Reference Networks initiative to solve undiagnosed rare diseases, connecting them to Europe's top rare disease research infrastructure.